Scarica l'app Stockscreener
225.48
0.14%
-0.3209
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$225.80
Aprire:
$226.1
Volume 24 ore:
73,308
Relative Volume:
0.08
Capitalizzazione di mercato:
$16.82B
Reddito:
$2.88B
Utile/perdita netta:
$499.60M
Rapporto P/E:
33.45
EPS:
6.74
Flusso di cassa netto:
$321.60M
1 W Prestazione:
-2.13%
1M Prestazione:
+2.62%
6M Prestazione:
-26.59%
1 anno Prestazione:
-41.92%
Intervallo 1D:
$222.73
$226.82
Intervallo di 1 settimana:
$222.73
$234.02
Portata 52W:
$197.01
$397.72
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Confronta WST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
225.01 | 16.82B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
514.07 | 182.21B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.30 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.44 | 45.01B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
223.97 | 32.73B | 4.93B | 1.25B | 1.38B | 8.47 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance UK
Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq
Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com
West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK
UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada
UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire
This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga India
Evercore ISI sets $275 target on West Pharmaceutical stock - Investing.com
Evercore ISI sets $275 target on West Pharmaceutical stock By Investing.com - Investing.com UK
Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target - Marketscreener.com
Managing Risks In Injectable Drug Delivery Solutions For Todays Drug Products And Tomorrows Novel Applications - BioProcess Online
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges - Investing.com India
West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsWST - ACCESS Newswire
On-Body Drug Delivery Devices Market to Hit $ 82.74 Bn by 2033Key - openPR
Jones Financial Companies Lllp Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Announces Leadership Transition - TipRanks
Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online
Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services to Present at Major 2025 Healthcare Conferences - MSN
Zacks Research Has Bearish Estimate for WST Q1 Earnings - Defense World
Why West Pharmaceutical Services, Inc. (WST) Is Plunging So Far In 2025 - Insider Monkey
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) - Yahoo Finance
FY2027 Earnings Forecast for WST Issued By Zacks Research - Defense World
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet - Simply Wall St
West to Participate in Upcoming Investor Conferences -March 05, 2025 at 06:01 am EST - Marketscreener.com
West to Participate in Upcoming Investor Conferences - Quantisnow
Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Private Advisor Group LLC Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Achieving EU GMP Annex 1 Compliance Through An End-To-End Approach To Contamination Control - Med Device Online
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $344.00 Consensus Target Price from Brokerages - Defense World
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire
Healthcare Visual Inspection Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
West Pharmaceutical Services Declares $0.21 Dividend for Q2 2025 - MSN
West Pharmaceutical Services: How GLP-1 and Biologics Are Unlocking Explosive Growth! - Smartkarma
Top 2 Health Care Stocks That May Rocket Higher This Month - Benzinga
West Pharmaceutical sets Q2 dividend at $0.21 per share By Investing.com - Investing.com Australia
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):